Alvotech ALVO
NASDAQ ALVO
$5.32 -0.06 (-1.12%)
At close: Sep 4, 2026 · 4:00 PM EDT

Alvotech (ALVO) Amortization of Deferred Charges (2021 - 2026)

Alvotech's (ALVO) quarterly Amortization of Deferred Charges came in at $41.0 million in Q2 2026, up 11.93% on a YoY basis from $36.7 million in Q2 2025, and up 0.53% quarter-over-quarter from $40.8 million in Q1 2026.

Analysis

Alvotech (ALVO) Amortization of Deferred Charges (2021 - 2026) Analysis & Trends

Alvotech (ALVO) has reported Amortization of Deferred Charges for 6 consecutive years, with $41.0 million the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Amortization of Deferred Charges rose 11.93% year-over-year to $41.0 million; the trailing twelve-month figure through Jun 2026 stood at $158.8 million (up 62.17% YoY), and the FY2025 full-year result was $149.2 million, down 50.79% from the prior year.
  • Amortization of Deferred Charges rose to $41.0 million in Q2 2026 per ALVO's latest filing, from $40.8 million in the prior quarter.
  • Across five years, Amortization of Deferred Charges topped out at $184.1 million in Q1 2024 and bottomed at -$143.3 million in Q2 2023.
  • Historically, Amortization of Deferred Charges has averaged $50.1 million across 5 years, with a median of $40.9 million in 2026.
  • The sharpest annual moves came in 2023 and 2025: Amortization of Deferred Charges sank 541.36% in 2023, then jumped 516.53% in 2025.
  • Over 5 years, Amortization of Deferred Charges stood at $119.2 million in 2022, then soared by 33.65% to $159.3 million in 2023, then sank by 58.9% to $65.5 million in 2024, then sank by 235.14% to -$88.5 million in 2025, then jumped by 146.36% to $41.0 million in 2026.
  • According to Business Quant data, Amortization of Deferred Charges over the past three periods registered $41.0 million, $40.8 million, and -$88.5 million for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Teva Pharmaceutical Industries 42.34 Bn 38.68 Bn 2.15 Bn
2 Viatris 19.39 Bn 18.50 Bn 1.46 Bn
3 Dr Reddys Laboratories 9.99 Bn 9.85 Bn 396.53 Mn
4 Amneal Pharmaceuticals 5.57 Bn 5.53 Bn 334.51 Mn
5 Bausch Health Companies 2.45 Bn 1.58 Bn 2.10 Bn
6 Ani Pharmaceuticals 1.70 Bn 1.34 Bn 165.89 Mn
7 Alvotech 1.66 Bn 1.52 Bn 2.56 Mn
8 Amphastar Pharmaceuticals 985.90 Mn 695.77 Mn 93.47 Mn
9 Fennec Pharmaceuticals 434.07 Mn 392.82 Mn 17.15 Mn
10 NutriBand 72.57 Mn 69.15 Mn 181,874.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 41.02 Mn
Mar 31, 2026 40.81 Mn
Dec 31, 2025 -88.49 Mn
Sep 30, 2025 165.49 Mn
Jun 30, 2025 36.65 Mn
Mar 31, 2025 35.54 Mn
Dec 31, 2024 65.48 Mn
Sep 30, 2024 -39.73 Mn
Jun 30, 2024 93.35 Mn
Mar 31, 2024 184.06 Mn
Dec 31, 2023 159.33 Mn
Jun 30, 2023 -143.30 Mn
Dec 31, 2022 119.22 Mn
Jun 30, 2022 32.47 Mn
Dec 31, 2021 -39.99 Mn
Sep 30, 2021 33.78 Mn